CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLDI CALIDI BIOTHERAPEUTICS INC

交易中 10-22 15:43:13 EDT

0.6324

-0.1356

-17.66%

最高0.7672	最低0.6200	成交量17.14万
今开0.7671	昨收0.7680	日振幅19.17%
总市值233.09万	流通市值231.28万	总股本368.58万
成交额12.10万	换手率4.69%	流通股本365.71万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLDI","market":"US","secType":"STK","nameCN":"CALIDI BIOTHERAPEUTICS INC","latestPrice":0.6324,"timestamp":1792698188798,"preClose":0.768,"halted":0,"volume":171359,"delay":0,"changeRate":-0.17656250000000007,"floatShares":3657100,"shares":3685800,"eps":-33.337368,"marketStatus":"交易中","change":-0.1356,"latestTime":"10-22 15:43:13 EDT","open":0.7671,"high":0.7672,"low":0.62,"amount":121011.0697355,"amplitude":0.191667,"askPrice":0.6999,"askSize":1700,"bidPrice":0.61,"bidSize":250,"shortable":0,"etf":0,"ttmEps":-33.337368,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":0.768,"preHourTrading":{"tag":"盘前","latestPrice":0.7501,"preClose":0.768,"latestTime":"09:22 EDT","volume":696,"amount":503.2136376,"timestamp":1792675338949,"change":-0.0179,"changeRate":-0.023307,"amplitude":0.139844},"volumeRatio":4.364421},"requestUrl":"/m/hq/s/CLDI","defaultTab":"news","newsList":[{"id":"1154283209","title":"Calidi宣布反向股票分割，预计将于2026年7月31日以1比16的调整后比例开始交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1154283209","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154283209?lang=zh_cn&edition=full","pubTime":"2026-07-21 04:32","pubTimestamp":1784579569,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics Inc宣布将进行反向股票分割，预计公司股票将于2026年7月31日以1比16的调整后比例开始交易。此举旨在调整公司的股本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154584198","title":"Calidi Biotherapeutics任命前基因泰克/罗氏与Celgene高管Corsee Sanders博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1154584198","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154584198?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:03","pubTimestamp":1782216238,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics宣布，任命在生物技术领域拥有丰富经验的前基因泰克/罗氏及Celgene公司高管Corsee Sanders博士加入其董事会。此项人事任命旨在强化公司的战略指导与治理能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4505","LEGN","BK4139","CLDI","RARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124481970","title":"Calidi Biotherapeutics获美国FDA对Cld-401的积极Pre-IND反馈，就当前开发策略达成一致，推进首次人体研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1124481970","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124481970?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:01","pubTimestamp":1781611291,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics公司宣布，其候选疗法Cld-401已获得美国食品药品监督管理局（FDA）积极的Pre-IND（研究性新药申请前）会议反馈。这一进展标志着监管机构与公司就Cld-401当前的整体开发策略达成共识，为推进该疗法进入首次人体临床研究扫清了关键路径。公司正基于此反馈，积极准备后续的IND申请工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178176076","title":"Calidi Biotherapeutics：目标年底前提交CLD-401监管申请，首个人体试验拟于2027年初启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1178176076","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178176076?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:00","pubTimestamp":1781611259,"startTime":"0","endTime":"0","summary":"Calidi Biotherapeutics公司宣布，其目标是在今年年底前完成候选疗法CLD-401的监管申请提交。若进展顺利，公司计划于2027年初启动该疗法的首次人体临床试验。这一时间表标志着该公司在推进其新型生物治疗平台方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116899755","title":"Calidi Biotherapeutics与Transferai达成战略合作 运用智能代理AI优化Cld-401新药临床申请流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1116899755","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116899755?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:01","pubTimestamp":1777464078,"startTime":"0","endTime":"0","summary":"生物技术公司Calidi Biotherapeutics近日宣布与人工智能企业Transferai建立战略合作伙伴关系。双方将重点运用智能代理人工智能技术，显著提升抗癌候选药物Cld-401的新药临床试验申请准备工作的效率。通过此次合作，Calidi计划借助Transferai先进的AI解决方案优化IND申报流程中的关键环节。Cld-401作为Calidi公司核心的肿瘤治疗候选药物，此次与AI技术企业的合作标志着其商业化进程进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227961","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅下挫5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227961?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615251,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速跳水5.64%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022005198a2a4be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022005198a2a4be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517049910","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅上涨6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517049910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517049910?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185035,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅拉升6.81%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223035963adbed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223035963adbed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516217658","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516217658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516217658?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017224,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速下挫5.63%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235344abe64ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235344abe64ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514861543","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下挫6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514861543?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:59","pubTimestamp":1740668382,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时59分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速跳水6.15%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272259429632b718&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272259429632b718&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856304","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速上涨5.72%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856304?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速拉升5.72%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505abddedd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505abddedd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514905930","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大跌5.26%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514905930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514905930?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:39","pubTimestamp":1740494381,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时39分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速下跌5.26%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522394198924e9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522394198924e9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513272240","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大涨5.71%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513272240?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:34","pubTimestamp":1740407642,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时34分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速拉升5.71%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223402a2521502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223402a2521502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513829734","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下跌5.43%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513829734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513829734?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:10","pubTimestamp":1740154228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时10分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅下挫5.43%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222001028988df3ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222001028988df3ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512198030","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下跌5.51%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512198030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512198030?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:47","pubTimestamp":1739900871,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时47分，Calidi Biotherapeutics, Inc.股票出现异动，股价急速下跌5.51%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190147519627b79d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190147519627b79d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525122","title":"Calidi Biotherapeutics, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525122?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:36","pubTimestamp":1739457369,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时36分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速下跌5.33%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132236099621bcf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132236099621bcf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510009387","title":"Calidi Biotherapeutics, Inc.盘中异动 急速下挫6.06%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510009387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510009387?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:37","pubTimestamp":1739284643,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时37分，Calidi Biotherapeutics, Inc.股票出现波动，股价大幅下跌6.06%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112237239881be2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112237239881be2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863478","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘股价大涨7.69%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863478?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197863,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Calidi Biotherapeutics, Inc.股票出现波动，股价急速上涨7.69%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223103abc9a499&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223103abc9a499&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744676","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速下跌10.14%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744676?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:31","pubTimestamp":1738938694,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时31分，Calidi Biotherapeutics, Inc.股票出现异动，股价急速下跌10.14%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223134a23d231c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223134a23d231c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLDI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272320","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘急速上涨8.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509272320?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852281,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Calidi Biotherapeutics, Inc.股票出现异动，股价快速拉升8.09%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223121a23bce0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223121a23bce0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508457650","title":"Calidi Biotherapeutics, Inc.盘中异动 早盘大幅下挫5.43%报0.993美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508457650?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:34","pubTimestamp":1738679670,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时34分，Calidi Biotherapeutics, Inc.股票出现异动，股价急速下挫5.43%。Calidi Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Calidi Biotherapeutics, Inc.公司简介：Calidi Biotherapeutics Inc 是一家临床阶段的免疫肿瘤学公司，致力于开发和商业化新型、强效和高效的基于干细胞的平台，用于递送和增强用于治疗癌症的溶瘤病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223430abc228cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223430abc228cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLDI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calidibio.com","stockEarnings":[{"period":"1week","weight":-0.1213},{"period":"1month","weight":-0.3095},{"period":"3month","weight":-0.5429},{"period":"6month","weight":-0.7876},{"period":"1year","weight":-0.9684},{"period":"ytd","weight":-0.959}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Calidi Biotherapeutics, Inc.于2021年3月24日在特拉华州注册成立。该公司是一家公开交易的生物技术公司，率先利用其RedTail平台开发靶向疗法，该平台是一种工程化包膜溶瘤病毒，设计用于系统递送至转移部位。其主要候选药物CLD-401将IL-15超激动剂递送至肿瘤微环境，预计于2026年底提交新药临床试验申请。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.185839},{"month":2,"riseRate":0.6,"avgChangeRate":-0.062337},{"month":3,"riseRate":0.4,"avgChangeRate":-0.220856},{"month":4,"riseRate":0.2,"avgChangeRate":-0.161642},{"month":5,"riseRate":0.2,"avgChangeRate":-0.101283},{"month":6,"riseRate":0.6,"avgChangeRate":-0.072029},{"month":7,"riseRate":0.6,"avgChangeRate":0.19684},{"month":8,"riseRate":0.2,"avgChangeRate":-0.270044},{"month":9,"riseRate":0,"avgChangeRate":-0.186616},{"month":10,"riseRate":0.6,"avgChangeRate":-0.113657},{"month":11,"riseRate":0.5,"avgChangeRate":0.188661},{"month":12,"riseRate":0.2,"avgChangeRate":-0.191351}],"exchange":"AMEX","name":"CALIDI BIOTHERAPEUTICS INC","nameEN":"CALIDI BIOTHERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CALIDI BIOTHERAPEUTICS INC(CLDI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CALIDI BIOTHERAPEUTICS INC,CLDI,CALIDI BIOTHERAPEUTICS INC股票,CALIDI BIOTHERAPEUTICS INC股票老虎,CALIDI BIOTHERAPEUTICS INC股票老虎国际,CALIDI BIOTHERAPEUTICS INC行情,CALIDI BIOTHERAPEUTICS INC股票行情,CALIDI BIOTHERAPEUTICS INC股价,CALIDI BIOTHERAPEUTICS INC股市,CALIDI BIOTHERAPEUTICS INC股票价格,CALIDI BIOTHERAPEUTICS INC股票交易,CALIDI BIOTHERAPEUTICS INC股票购买,CALIDI BIOTHERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALIDI BIOTHERAPEUTICS INC(CLDI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CALIDI BIOTHERAPEUTICS INC(CLDI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}